First Indian Guidelines on Immunophenotyping!!

Day	TWO PARALLEL WORKSHOPS (March 13, 2008)
Day1 - March 13	SESSIONS	Speakers
8.00 – 8.45 AM 8.45 – 9.30 AM	Plenary session 1- Minimal Residual Disease Plenary session 2- Minimal Residual Disease (Alternative perspective)	Dario Compana Mike Borowitz
9.30 – 10.30AM	Plenary session 3  – Introduction to FCM data analysis in Hematolymphoid Malignancies	Brent Wood
10.30-11.00 AM	TEA
11.00 AM onwards	Simultaneous Workshops Workshop 1 -  Minimal residual disease Workshop 2 -  FCM data analysis in Hematolymphoid Malignancies	Dario, Elaine Coustan-Smith Brent, Mike Borowitz
7.00 PM	COCKTAIL AND DINNER
	TWO DAYS MEETING ON GUIDELINES (March 14-15, 2008)
Day 2 – March14	TOPICS	Speakers
8.00 - 8.15 AM	Welcome
8.15 – 8.45 AM	Indications for FCM in hematological malignancies	Mike
8.45 – 9.00 AM	Suggested panel for acute leukemia – Indian Perspective	Subramanian
9.00 – 9.45 AM	Critique - Panel selection for acute leukemia - European perspective	Maria
9.45 - 10.30 AM	Critique - Panel selection for acute leukemia - American Perspective	Brent
10.30 -11.00 AM	TEA
11.00 – 1.00 PM	Panel discussion on guidelines for panel selection in acute leukemias –  MB Agarwal	Dario, Brent, Rajive, Banavali
1.00 – 2.00 PM	LUNCH
2.00 - 2.15 PM	Suggested panel for mature lymphoma – Indian Perspective	Amar
2.15 – 3.00 PM	Critique - Panel selection for mature B/T cell lymphomas - European perspective	Estella
3.00 - 3.45 PM	Critique – Panel selection for mature B/T cell neoplasm - American Perspective	Mike
3.45 – 5.45 PM	Panel discussions on guidelines of panel selection in mature lymphomas - S Gupta	Estella, Mike, Maria, Borges
5.45 - 6.30 PM	Circulating endothelial cells and Endothelial progenitor cells: Emerging Biomarkers	Phil
7.00 PM	COCKTAIL AND DINNER
Day3 – March15
8 - 8.15 AM	Consensus for Immunophenotyping panel in lymphoma	Amar
8.15 – 8.30 AM	Consensus for Immunophenotyping panel in acute leukemia	Subramanian
8.30 – 9.00 AM	Evolution of hematopoietic stem cell assays	Phil
9.00 – 9.30 AM	QC issues in stem cell assays	Mary Sartor
9.30 – 10.00 AM	EQAS in immunophenotyping	Mary Sartor
10.00 – 11.00 AM	Panel discussion on stem cell counts – The Indian Scenario– N Khattry	Mary, Velu, Badri, Ashish
11.00 – 11.15AM	TEA
11.15 - 11.30AM	Training  of Cytometrists – Indian perspective	Gujral
11.30 – 12.00PM	Training  of Cytometrists – European perspective	Estella
12.00 - 12.30PM	Training of Cytometrists – US perspective	Brent
12.30 - 1.30 PM	Panel discussion on training cytometrists in India – Awtar Krishan	Mike, Dario, Maria, Krishnamurthy, Ghosh, Neelam
1.30 - 2.30 PM	LUNCH
2.30 - 3.00 PM	QC issues  - sample collection, preservation, storage and transportation	Elaine
3.00 - 3.30 PM	QC issues  - sample processing, and instrument setup	Mary
3.30 - 4.00 PM	QC issues – Acquisition, analysis, interpretation and reporting	Maria
4.00 - 5.30 PM	Panel discussion on quality control issues – Mary	Elaine, Estella, Brent, Swati, Martin
5.30 PM	Concluding remarks